The US Food and Drug Administration (FDA) has issued a Class I recall for the t:connect mobile app on iOS, which is used to monitor and control the t:slim X2 insulin pump used by people with diabetes.

Insulin pumps are a medical device used by people with diabetes to automatically deliver a measured dose of insulin into their bloodstream. Traditionally they have involved a canula and separate ...

Tandem Diabetes Care says the Food and Drug Administration (FDA) has cleared its smartphone app to program and cancel insulin doses from the t:slim X2 insulin pump. The company claims it's the first ...

The next big thing on Tandem Diabetes Care’s technology slate is actually a very small thing. The Mobi insulin pump—which is the company's smallest device to date and, it claims, the smallest ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA granted 510(k) clearance for a tubeless insulin ...

Johnson & Johnson has warned its customers about a security vulnerability in one of its insulin pumps. If the flaw in the Animas OneTouch Ping insulin pump was exploited, it could allow an attacker to ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced ...

April 5, 2006 — The US Food and Drug Administration (FDA) and Disetronic Medical Systems, Inc (owned by Roche Diagnostics) have notified healthcare professionals regarding the voluntary nationwide ...

Two years after submitting the latest version of its insulin pump technology for FDA approval—and three years after it was first made available in Europe—Medtronic has finally secured the agency’s ...

Medical device company Medtronic issued an urgent recall of the remote controller for certain insulin pumps because they’re vulnerable to hacks. It’s possible for someone to copy the signals sent from ...

MADRID — Airplane travel consistently causes insulin pumps to over-deliver a little over half a unit on takeoff and under-deliver a bit less on landing, new research found. This phenomenon is due to ...